<DOC>
	<DOC>NCT01077570</DOC>
	<brief_summary>This study is conducted in Asia. The aim of this observational study is, under normal clinical practice conditions, to investigate the clinical safety and effectiveness in Chinese patients with type 2 diabetes who have never received anti-diabetic treatment before.</brief_summary>
	<brief_title>An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<criteria>HbA1c more than 6.5%, no antidiabetes treatment accepted before entering the study Subjects who received any antidiabetic treatment previously Known or suspected allergy to trial product(s) or related products. Subjects who previously enrolled in this study. Females of childbearing potential who are pregnant, breastfeeding or intend to become pregnant or are not using adequate contraceptive methods.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>